András Horváth1,2, Anna Szűcs2, Zoltán Hidasi3, Gábor Csukly3, Gábor Barcs2, Anita Kamondi2,4. 1. Department of Anatomy, Histology and Embryology, Semmelweis University, Budapest, Hungary. 2. National Institute of Clinical Neurosciences, Hungary. 3. Department of Psychiatry and Psychotherapy, Semmelweis University, Budapest, Hungary. 4. Department of Neurology, Semmelweis University, Budapest, Hungary.
Abstract
BACKGROUND: Alzheimer's disease (AD) is the primary cause of cognitive decline. A growing body of evidence suggests that AD patients have a higher risk to develop epileptic seizures; however, results are contradictory due to different methodological approaches of previous studies. OBJECTIVE: We aimed to identify the prevalence, semiology, and risk factors of epilepsy in AD using long-term EEG. METHODS: We selected forty-two AD patients and examined them using 24-hour ambulatory EEG. Neurological and epileptological data were collected with retro- and prospective methods. We analyzed the semiology of the identified seizures and the possible risk factors using logistic regression analysis. RESULTS: We identified seizures confirmed by EEG in 24%. The majority of the seizures were aware focal (72%) without any motor activity (55%). We found epileptiform discharges without seizures in 28%. Patients with seizures and only with epileptic EEG activity showed similar clinical and demographical features. Higher education (OR:1.8) and lower Addenbrooke Examination Score (OR: 0.9) were identified as risk factors of epilepsy. Increase of 0.1 point in the Verbal-Language/Orientation-Memory ratio (VLOM) was associated with higher epilepsy risk as well (OR:2.9). CONCLUSION: Epilepsy is a frequent comorbidity of AD. Since most of the seizures are aware non-motor focal seizures, sensitive EEG techniques are required for precise diagnosis of epilepsy. Long-term ambulatory EEG is a safe and well-tolerated option. Epileptiform EEG in AD signals the presence of concomitant epilepsy. Clinicians have to pay attention to comorbid epilepsy in dementia patients with high education, with high VLOM ratio and severe stage.
BACKGROUND:Alzheimer's disease (AD) is the primary cause of cognitive decline. A growing body of evidence suggests that ADpatients have a higher risk to develop epileptic seizures; however, results are contradictory due to different methodological approaches of previous studies. OBJECTIVE: We aimed to identify the prevalence, semiology, and risk factors of epilepsy in AD using long-term EEG. METHODS: We selected forty-two ADpatients and examined them using 24-hour ambulatory EEG. Neurological and epileptological data were collected with retro- and prospective methods. We analyzed the semiology of the identified seizures and the possible risk factors using logistic regression analysis. RESULTS: We identified seizures confirmed by EEG in 24%. The majority of the seizures were aware focal (72%) without any motor activity (55%). We found epileptiform discharges without seizures in 28%. Patients with seizures and only with epileptic EEG activity showed similar clinical and demographical features. Higher education (OR:1.8) and lower Addenbrooke Examination Score (OR: 0.9) were identified as risk factors of epilepsy. Increase of 0.1 point in the Verbal-Language/Orientation-Memory ratio (VLOM) was associated with higher epilepsy risk as well (OR:2.9). CONCLUSION:Epilepsy is a frequent comorbidity of AD. Since most of the seizures are aware non-motor focal seizures, sensitive EEG techniques are required for precise diagnosis of epilepsy. Long-term ambulatory EEG is a safe and well-tolerated option. Epileptiform EEG in AD signals the presence of concomitant epilepsy. Clinicians have to pay attention to comorbid epilepsy in dementiapatients with high education, with high VLOM ratio and severe stage.
Authors: Andras Attila Horvath; Emoke Anna Csernus; Sara Lality; Rafal M Kaminski; Anita Kamondi Journal: Front Neurosci Date: 2020-10-15 Impact factor: 4.677
Authors: Xinshi Wang; Samantha M Loi; Emma Foster; Zhibin Chen; Dennis Velakoulis; Patrick Kwan Journal: Front Aging Neurosci Date: 2021-03-16 Impact factor: 5.750
Authors: J M Wilcox; D C Consoli; A A Tienda; S Dixit; R A Buchanan; J M May; W P Nobis; F E Harrison Journal: Neurobiol Dis Date: 2021-08-24 Impact factor: 5.996
Authors: Alice D Lam; Rani A Sarkis; Kyle R Pellerin; Jin Jing; Barbara A Dworetzky; Daniel B Hoch; Claire S Jacobs; Jong Woo Lee; Daniel S Weisholtz; Rodrigo Zepeda; M Brandon Westover; Andrew J Cole; Sydney S Cash Journal: Neurology Date: 2020-08-06 Impact factor: 9.910
Authors: Rosalyn Hithersay; Carla M Startin; Sarah Hamburg; Kin Y Mok; John Hardy; Elizabeth M C Fisher; Victor L J Tybulewicz; Dean Nizetic; André Strydom Journal: JAMA Neurol Date: 2019-02-01 Impact factor: 18.302